Tag:
Cytos
Latest Headlines
Latest Headlines
Novartis, Cytos Alzheimer's vax shows immune response
CAD106, a vaccine co-developed by Novartis and Cytos that targets the amyloid β peptide, has shown early hints of immune responses in a clinical trial in people with Alzheimer's disease. This vaccine could have potential to slow the development of the disease.
Cytos touts one-size-fits-all vax, hints at $541M deal
Swiss researchers claim to have found a 'one size fits all' allergy shot for hay fever, asthma and eczema, adding that it could be available within four to five years, the Telegraph reports. The
Pfizer teams with Cytos to develop new vaccines
Further bolstering its ambitious vaccine program, Pfizer has teamed up with Cytos Biotechnology to develop, manufacture and commercialize vaccines for a defined number of human diseases. Cytos gains
Cytos' blood pressure vax data shows new approach
New data from a small human study of Cytos' blood pressure vaccine has stirred
